Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Prevention of Alzheimer'S Disease|March 29, 2016
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS)A M Wessels, E R Siemers, P Yu, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task ForceS Gauthier, J Alam, H Fillit, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's DiseaseR A Rissman, M C Donohue, O Langford, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled TrialR Raman, K Hussen, M C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814)J R Sims, K J Selzler, A M Downing, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 ImagingS L Lowe, C Duggan Evans, S Shcherbinin, et al.
The Review of Scientific Instruments|November 7, 2012
Gamma-to-electron magnetic spectrometer (GEMS): an energy-resolved γ-ray diagnostic for the National Ignition FacilityY Kim, H W Herrmann, T J Hilsabeck, et al.
Physical Review Letters|October 13, 2007
Fermi surface of CeIn3 above the Néel critical fieldN Harrison, S E Sebastian, C H Mielke, et al.
Pageof 3